Resources | NITAG RESOURCE CENTER

2023 ∙ Kumar, G. Jena, S. Snigdha, N. T. Basha, S. Narayanan, J. K. Luke, A. M.

Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis

2023 ∙ Dey, S. Kusuma, Y. S. Kant, S. Kumar, D. Gopalan, R. B. Sridevi, P. Aggarwal, S.

COVID-19 vaccine acceptance and hesitancy in Indian context: a systematic review and meta-analysis

2023 ∙ Suhail, M. K. Moinuddin, A.

Evaluation of strategies against vaccine hesitancy in the COVID-19 and Indian context-A systematic review

2023 ∙ Liu, Y. Kuang, K.

Predictors of COVID-19 vaccination hesitancy in China: a meta-analysis

2023 ∙ Garg, R. K. Paliwal, V. Malhotra, H. S. Singh, B. P. Rizvi, I. Kumar, N.

Spectrum of Serious Neurological and Psychiatric Adverse Events in Indian COVID-19 Vaccine Recipients: A Systematic Review of Case Reports and Case Series

2023 ∙ ATAGI

ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines

2023 ∙ ATAGI

ATAGI Update on the COVID-19 Vaccination Program

2023 ∙ ATAGI

ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older

2023 ∙ ATAGI

ATAGI 2023 booster advice

2023 ∙ ATAGI

ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine